Atrial Fibrillation
Conditions
Brief summary
This is a prospective, observational study that will examine endothelial dysfunction in atrial fibrillation before and after treatment with anti-arrhythmic agents and the extent to which baseline endothelial dysfunction improves after treatment.
Detailed description
This will be a prospective, observational study and roughly 60 patients will be recruited based on strict inclusion/exclusion criteria. Goal population includes adult patients with a diagnosis of paroxysmal or persistent atrial fibrillation seen in the electrophysiology clinic and admitted to the UPMC Presbyterian electrophysiology service for initiation of anti-arrhythmic medications. The primary goal of the study will be to evaluate the degree of endothelial function recovery seen after initiating anti-arrhythmic medical therapy. We will assess genetic markers, arterial stiffness and vasodilation in response to acetylcholine iontophoresis, nitroprusside iontophoresis, local thermal hyperemia and reactive hyperemia. Laser speckle contrast imaging will be employed to evaluate the microvasculature. SphygmoCor (arterial tonometry) will be used to assess macrovasculature. Testing will be performed at baseline prior to the 1st dose of anti- arrhythmic therapy and repeated again 1-3 months later at outpatient follow-up visit. Additionally, follow-up phone calls or office visits will take place at 6 and 12 months after the initial data collection visit to document recurrence rate of atrial fibrillation.
Interventions
DRUGSotalol
The primary goal of the study will be to evaluate the change in endothelial function seen after initiating anti-arrhythmic medical therapy. Testing will be performed at baseline prior to the 1st dose of anti-arrhythmic therapy and again 1-3 months later at outpatient follow-up visit. We will record the resting flow (RF), biological zero (BZ) and peak flow (PF) as perfusion units (PU). Specifically, we will assess arterial stiffness and vasodilation in response to acetylcholine iontophoresis, nitroprusside iontophoresis, local thermal hyperemia and reactive hyperemia. Laser speckle contrast imaging will be employed to evaluate the microvasculature. SphygmoCor (arterial tonometry) will be used to assess macrovasculature.
DRUGDofetilide
Same as described above with sotalol.
Sponsors
Samir Saba
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Inclusion criteria
* Adult patients (18-75 years of age) with paroxysmal or persistent atrial fibrillation * Patients who recovered from prior tachycardia induced cardiomyopathy will be allowed to enroll in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in microvascular endothelium dependent dilation following anti-arrhythmic therapy as measured in perfusion units | 1 year | Change in microvascular endothelium dependent dilation (in response to acetylcholine) assessed with laser speckle contrast imaging after initiating antiarrhythmic medical therapy. |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between microvascular endothelial function improvement with antiarrhythmic medications and atrial fibrillation recurrence. | 1 year |
| Correlation between microvascular endothelial function and atrial fibrillation severity represented by left atrial size and type of Afib (paroxysmal vs persistent). | 1 year |
| Change in other vasodilation dysfunction indices measured after initiating antiarrhythmic medical therapy. | 1 year |
| Correlation between microvascular endothelial dysfunction measured at baseline and atrial fibrillation recurrence. | 1 year |
| Whether missense mutation in Cyb5R3 T117S can predict atrial fibrillation recurrence. | 1 year |
| Whether missense mutation in Cyb5R3 T117S is correlated with atrial fibrillation severity. | 1 year |
| Correlation between vasodilation dysfunction indices measured at baseline and atrial fibrillation recurrence. | 1 year |
Countries
United States
Outcome results
None listed